Business First Bancshares Inc
For the period ended Dec 31, 2024. Filed Mar 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 7, 2025
BFST$32.73-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash Flows From Operating Activities: | |||
| Consolidated Net Income | $65,107 | $71,043 | $54,255 |
| Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: | |||
| Provision for Credit Losses | 10,873 | 4,483 | 10,886 |
| Depreciation and Amortization | 5,257 | 4,670 | 4,818 |
| Net Accretion of Purchase Accounting Adjustments | (2,505) | (7,615) | (7,949) |
| Stock Based Compensation Cost | 2,999 | 3,999 | 3,696 |
| Net Amortization of Securities | 2,140 | 4,197 | 6,005 |
| (Gain) Loss on Sales of Securities | (7) | 2,565 | 48 |
| Gain on Sale Loans | (2,376) | (671) | (398) |
| Income on Other Equity Securities | (2,201) | (3,045) | (1,554) |
| (Gain) Loss on Sale of Other Real Estate Owned, Net of Writedowns | (89) | (214) | 92 |
| Increase in Cash Value of Life Insurance | (2,875) | (2,247) | (1,931) |
| Deferred Income Tax Benefit | (962) | (2,052) | (1,368) |
| Gain on Sale of Branch | - | (945) | - |
| Changes in Assets and Liabilities: | |||
| Increase in Accrued Interest Receivable | (3,079) | (4,250) | (3,466) |
| (Increase) Decrease in Other Assets | 9 | (1,683) | 6,075 |
| Increase (Decrease) in Accrued Interest Payable | (10,498) | 12,749 | 519 |
| Increase (Decrease) in Other Liabilities | (391) | 11,443 | (151) |
| Net Cash Provided by Operating Activities | 61,402 | 92,427 | 69,577 |
| Cash Flows From Investing Activities: | |||
| Purchases of Securities Available for Sale | (104,165) | (131,038) | (102,809) |
| Proceeds from Maturities / Sales of Securities Available for Sale | 40,720 | 91,981 | 38,951 |
| Proceeds from Paydowns of Securities Available for Sale | 67,864 | 53,916 | 95,019 |
| Net Cash Received in Acquisition | 96,824 | - | 163,460 |
| Net Cash Paid in Sale of Branch | - | (14,506) | - |
| Purchases of Other Equity Securities | (5,015) | (15,573) | (22,670) |
| Redemption of Other Equity Securities | 1,713 | 21,361 | 10,327 |
| Purchase of Life Insurance | (3,000) | (2,273) | (18,000) |
| Proceeds from Death Benefit of Cash Value of Life Insurance | 813 | - | 499 |
| Net Increase in Loans | (294,941) | (379,073) | (1,070,354) |
| Net Purchases of Premises and Equipment | (1,562) | (11,648) | (7,781) |
| Loss on Disposal of Premises and Equipment | 7 | - | 717 |
| Proceeds from Sales of Other Real Estate | 621 | 1,240 | 682 |
| Net Increase in Securities Purchased Under Agreements to Resell | (50,835) | - | - |
| Net (Increase) Decrease in Federal Funds Sold | (43,957) | (135,528) | 211,438 |
| Net Cash Used in Investing Activities | (294,913) | (521,141) | (700,521) |
(CONTINUED)
| Years Ended December 31, | |||||
|---|---|---|---|---|---|
| 2024 · 2023 · 2022 | |||||
| Cash Flows From Financing Activities: | |||||
| Net Increase in Deposits | 520,570 | 444,780 | 265,827 | ||
| Net Increase (Decrease) in Securities Sold Under Agreements to Repurchase | 3,736 | (1,323) | 1,087 | ||
| Net Increase (Decrease) in Federal Funds Purchased | - | (14,057) | 14,057 | ||
| Net Advances (Repayments) on Federal Home Loan Bank Borrowings | 122,488 | (198,902) | 327,203 | ||
| Net Proceeds (Repayments) on Bank Term Funding Program | (300,000) | 300,000 | - | ||
| Net Proceeds (Repayments) from Short Term Borrowings | - | - | (11) | ||
| Repayment of Subordinated Debt | - | (8,900) | - | ||
| Gain on Extinguishment of Debt | - | (1,458) | - | ||
| Proceeds from Issuance of Preferred Stock, Net of Issuance Costs | - | - | 71,930 | ||
| Net Proceeds (Costs) from Issuance of Common Stock | (31) | - | 48,492 | ||
| Surrendered Shares of Options Exercised | - | - | (1,102) | ||
| Payment of Dividends on Preferred Stock | (5,401) | (5,401) | (1,350) | ||
| Payment of Dividends on Common Stock | (14,863) | (12,655) | (10,824) | ||
| Net Cash Provided by Financing Activities | 326,499 | 502,084 | 715,309 | ||
| Net Increase in Cash and Cash Equivalents | 92,988 | 73,370 | 84,365 | ||
| Cash and Cash Equivalents at Beginning of Period | 226,110 | 152,740 | 68,375 | ||
| Cash and Cash Equivalents at End of Period | $319,098 | $226,110 | $152,740 | ||
| Supplemental Disclosures for Cash Flow Information: | |||||
| Cash Payments for: | |||||
| Interest on Deposits | $164,197 | $104,811 | $23,846 | ||
| Interest on Borrowings | $32,056 | $20,638 | $11,953 | ||
| Income Tax Payments | $17,352 | $16,095 | $13,550 | ||
| Supplemental Schedule for Noncash Investing and Financing Activities: | |||||
| Change in the Unrealized Gain (Loss) on Securities Available for Sale | $4,534 | $10,441 | $(93,466) | ||
| Change in the Unrealized Gain (Loss) on Equity Securities | $14 | $(782) | $874 | ||
| Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale and Equity Securities | $(961) | $(2,040) | $19,565 | ||
| Transfer of Loans to Other Real Estate | $4,376 | $1,339 | $719 | ||
| Acquisitions: | |||||
| Fair Value of Tangible Assets Acquired | $847,743 | $ | - | $531,510 | |
| Other Intangible Assets Acquired | 7,640 | - | 3,875 | ||
| Liabilities Assumed | 781,609 | - | 508,991 | ||
| Net Identifiable Assets Acquired Over Liabilities Assumed | $73,774 | $ | - | $26,394 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.